Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is the UK brand name for tirzepatide, a prescription medicine made by Eli Lilly. The same molecule goes by different names depending on the country and the condition it's treating — and getting them straight matters, because only Mounjaro is licensed for weight management in the UK. Tirzepatide is the international non-proprietary name (the generic, scientific name); Mounjaro is the brand under which Eli Lilly markets it here. In the United States, tirzepatide is also sold as Zepbound for weight loss and Mounjaro for type 2 diabetes — both names exist there, neither applies here. In the UK, if you're asking about weight management, the only name that counts is Mounjaro, and it is a prescription-only medicine requiring clinical assessment before anyone can supply it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every medicine has two layers of naming. The international non-proprietary name (INN) is the molecule's official scientific label, assigned by the World Health Organization and used by regulators, pharmacists and clinical researchers the same way worldwide. For this medicine, that name is tirzepatide. You'll see it in NICE's technology appraisal TA1026, in clinical papers, and in the Summary of Product Characteristics. It tells you precisely which compound is inside a pen, nothing more, nothing less.
Above the INN sits the brand name: the commercial label a manufacturer chooses for a specific market. Eli Lilly chose Mounjaro for both the UK and the European Union, covering both the weight-management and type 2 diabetes indications. So when a prescriber, a news story or a search result refers to "tirzepatide other names" or "other names for tirzepatide", they are really asking about this INN-versus-brand distinction, and in the UK, that answer is clean and simple. One brand. One pen. One supply chain.
This is also why the full picture of tirzepatide's naming conventions is worth understanding before you search: knowing the INN helps you recognise whether an overseas product description actually refers to the same molecule.
In the United States, Eli Lilly markets tirzepatide under two brand names: Mounjaro (licensed for type 2 diabetes) and Zepbound (licensed for weight loss). That split reflects a US regulatory decision, not a global one. In the UK, the MHRA granted a single authorisation under the name Mounjaro covering both indications. Zepbound does not exist as a UK product. It cannot be prescribed here, it is not on the UK market, and if you encounter a seller offering "Zepbound" pens in the UK, that is an immediate red flag for an unverified supply.
This matters practically. Counterfeit and unlicensed weight-loss pens do circulate online, the MHRA has published repeated warnings about fake pens sold through social-media channels and unregistered websites. A legitimate UK pharmacy can only dispense Mounjaro, sourced through the licensed UK supply chain. If a product is labelled with a name that doesn't match the UK-authorised brand, treat it with serious caution and report any suspect sellers via the Yellow Card scheme.
For anyone curious about what tirzepatide costs through a private UK clinic, the Mounjaro cost page explains how private pricing works and what a legitimate service actually includes.
Because tirzepatide and semaglutide (the molecule in Wegovy and Ozempic) are both associated with weight management in public conversation, their brand names get conflated constantly. They are distinct molecules with different mechanisms. Semaglutide activates one receptor, GLP-1. Tirzepatide activates two: GIP and GLP-1 simultaneously, making it the only dual-agonist weight-loss medicine licensed in the UK. The NHS medicines page for tirzepatide sets out its mechanism clearly for anyone who wants a plain-language reference.
The name overlap that trips most people up is Ozempic versus Wegovy, both are semaglutide, but Ozempic is licensed for type 2 diabetes and Wegovy for weight management. That distinction mirrors nothing in tirzepatide's naming, and our page on Mounjaro generic names explains why Mounjaro simply covers both indications under one name in the UK. Understanding this prevents a common error: assuming that any pen labelled "Ozempic" is appropriate for weight loss, or that the Mounjaro pen a GP prescribes for diabetes and the one from a weight-management clinic are different products. They're not. Same pen, same INN, same brand, the indication depends on why it was prescribed.
Our clinical team reviews every consultation individually, checking indication, eligibility and medical history before any prescription is issued.
The question of what Mounjaro's other brand names are has a practical edge beyond curiosity. If you're sourcing treatment privately, you can verify any online pharmacy on the GPhC register at pharmacyregulation.org/registers in under a minute, type in the pharmacy's name or registration number and confirm it appears as a registered premises. A pharmacy registered in the UK can only dispense UK-licensed, UK-sourced medicines. The pen it sends you will say Mounjaro on the label, because that is the only tirzepatide product that exists here.
If the label says anything else (Zepbound, an unfamiliar brand, or a strength that doesn't match the UK-licensed range of 2.5mg through to 15mg) don't use it. The MHRA's product authorisation is specific about the name, the doses and the manufacturer's batch traceability. Genuine supply chain traceability is one of the reasons a regulated pharmacy matters, not just for compliance but for your safety.
If you'd like to explore treatment through a GPhC-registered service with same-day clinical review, the free consultation page is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.